Casdin Partners Master Fund, L.P. - Aug 9, 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
10%+ Owner
Signature
Casdin Partners Master Fund LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
Stock symbol
BLFS
Transactions as of
Aug 9, 2023
Transactions value $
$771,744
Form type
4
Date filed
8/11/2023, 05:01 PM
Previous filing
May 23, 2023
Next filing
Oct 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock, par value $.001 per share Purchase $772K +58.5K +0.77% $13.20 7.63M Aug 9, 2023 Direct F1, F2
holding BLFS Common Stock, par value $.001 per share 150K Aug 9, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $13.1151 to $13.3998. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 The securities are owned directly by the Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.
F3 The securities are owned directly by a client of Casdin Capital and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin GP, the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Remarks:

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.